Противовирусный препарат Кагоцел и новый коронавирус SARS-CoV-2 (COVID-19)

Smartpharma® Awards 2019: Kagocel Is No.1 Remedy Against SARS and Flu


On May 22, 2019 Kagocel was recognized as the best drug in the nomination "Antiviral agent No.1 in Russia against influenza and SARS in adults and children from 3 years" according to Smartpharma® Awards 2019. The award was held under the auspices of the Doctor at Work company, the largest Russian-speaking social network for doctors. The winners were determined in a vote by pharmacy specialists in different categories. This year, the award winner selection process was held in an online format, and the well-deserved award itself was presented directly in the office of the winner - the manufacturer of Kagocel.

The head of Nearmedic Group Marketing and Advertising Department, Arkady Ivanchenko thanked the organizers of the award and the specialists having voted for their high appreciation of the drug: "Kagocel has been on the market for quite long - some 15 years. This year we are to produce the 200 millionth package. We are looking into the future with great hopes, anticipating in particular to expand our production portfolio and offer our consumers a range of new and interesting medical products."

Kagocel, recommended for the treatment and prevention of SARS and influenza in adults and children from 3 years, is a multiple winner of such awards as the Russian Pharma Awards, Green Cross, and Product of the Year. The drug has been widely recognized among both professionals and consumers, and has strengthened its status of an effective and safe remedy against influenza and SARS.

03.06.2019 12:30:00

← Back to the list